References
1. Pecorino B, Lagana AS, Chiantera V, Ferrara M, Di Stefano AB, Di Donna MC, et al. Progression Free Survival, Overall Survival, and Relapse Rate in Endometrioid Ovarian Cancer and Synchronous Endometrial-Ovarian Endometrioid Cancer (SEO-EC): Results from a Large Retrospective Analysis. Medicina (Kaunas). 2022;58(12).
2. Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-Analysis. J Clin Oncol. 2023;41(25):4065-76.
3. Ledermann JA, Raja FA, Fotopoulou C, Gonzalez-Martin A, Colombo N, Sessa C, et al. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Suppl 4):iv259.
4. Leitao MM, Jr., Chi DS. Surgical management of recurrent ovarian cancer. Semin Oncol. 2009;36(2):106-11.
5. Fortner RT, Trewin-Nybraten CB, Paulsen T, Langseth H. Characterization of ovarian cancer survival by histotype and stage: A nationwide study in Norway. Int J Cancer. 2023;153(5):969-78.
6. Bouchard-Fortier G, Panzarella T, Rosen B, Chapman W, Gien LT. Endometrioid Carcinoma of the Ovary: Outcomes Compared to Serous Carcinoma After 10 Years of Follow-Up. J Obstet Gynaecol Can. 2017;39(1):34-41.
7. Li S, Zhu Z. Chemotherapy is not necessary for early-stage serous and endometrioid ovarian cancer after undergoing comprehensive staging surgery. J Ovarian Res. 2020;13(1):91.
8. Maeda D, Shih Ie M. Pathogenesis and the role of ARID1A mutation in endometriosis-related ovarian neoplasms. Adv Anat Pathol. 2013;20(1):45-52.
9. Ayhan A, Mao TL, Seckin T, Wu CH, Guan B, Ogawa H, et al. Loss of ARID1A expression is an early molecular event in tumor progression from ovarian endometriotic cyst to clear cell and endometrioid carcinoma. Int J Gynecol Cancer. 2012;22(8):1310-5.
10. Makris GM, Manousopoulou G, Battista MJ, Salloum I, Chrelias G, Chrelias C. Synchronous Endometrial and Ovarian Carcinoma: A Case Series. Case Rep Oncol. 2017;10(2):732-6.
11. Singh N. Synchronous tumours of the female genital tract. Histopathology. 2010;56(3):277-85.
12. Le Thanh V, Bell R, Symons N, Soleymani Majd H. The role of multidisciplinary team and stepwise pelvic devascularization to minimize blood loss during total pelvic exenteration for patients refusing blood transfusion. Clin Case Rep. 2023;11(9):e7689.
13. Anglesio MS, Wang YK, Maassen M, Horlings HM, Bashashati A, Senz J, et al. Synchronous Endometrial and Ovarian Carcinomas: Evidence of Clonality. J Natl Cancer Inst. 2016;108(6):djv428.
14. Berek JS, Matias-Guiu X, Creutzberg C, Fotopoulou C, Gaffney D, Kehoe S, et al. FIGO staging of endometrial cancer: 2023. Int J Gynaecol Obstet. 2023;162(2):383-94.
15. Swift BE, Covens A, Mintsopoulos V, Parra-Herran C, Bernardini MQ, Nofech-Mozes S, et al. The effect of complete surgical staging and adjuvant chemotherapy on survival in stage I, grade 1 and 2 endometrioid ovarian carcinoma. Int J Gynecol Cancer. 2022;32(4):525-31.
16. Blank.
17. Addley S, Alazzam M, Johnson C, Soleymani Majd H. Rectovaginal extragastrointestinal stromal tumour (EGIST): an additional entity to be considered in the differential diagnosis of tumours of the rectovaginal septum. BMJ Case Rep. 2021;14(3).
18. Soleymani Majd H, Collins SL, Addley S, Weeks E, Chakravarti S, Halder S, et al. The modified radical peripartum cesarean hysterectomy (Soleymani-Alazzam-Collins technique): a systematic, safe procedure for the management of severe placenta accreta spectrum. Am J Obstet Gynecol. 2021;225(2):175 e1- e10.
19. Cowdell I, Smyth SL, Eltawab S, Soleymani Majd H. Radical abdomino-pelvic surgery in the management of uterine carcinosarcoma with concomitant para-aortic lymphadenopathy metastasising from anal carcinoma. BMJ Case Rep. 2022;15(11).
20. Khan M, Eltawab S, Gietzmann W, Soleymani Majd H. Laterally extended endopelvic resection as part of the surgical management of disseminated retroperitoneal leiomyomatosis mimicking low-grade sarcoma in a patient with a solitary kidney. BMJ Case Rep. 2023;16(6).
21. Cowie P, Eastwood B, Smyth S, Soleymani Majd H. Atypical presentation of intravascular leiomyomatosis mimicking advanced uterine sarcoma: modified laterally extended endopelvic resection with preservation of pelvic neural structures. BMJ Case Rep. 2021;14(9).
22. Guerrisi R, Smyth SL, Ismail L, Horne A, Ferrari F, Soleymani Majd H. Approach to Radical Hysterectomy for Cervical Cancer in Pregnancy: Surgical Pathway and Ethical Considerations. J Clin Med. 2022;11(24).
23. Smyth SL, Siddiqi A, Athanasou N, Whitwell D, Soleymani Majd H. Adamantinoma: A review of the current literature. J Bone Oncol. 2023;41:100489.
24. Smyth S, Addley S, Alazzam M, Soleymani Majd H. Adamantinoma: metastatic disease masquerading as a gynaecological malignancy. BMJ Case Rep. 2021;14(6).
25. Tozzi R, Hardern K, Gubbala K, Garruto Campanile R, Soleymani Majd H. En-bloc resection of the pelvis (EnBRP) in patients with stage IIIC-IV ovarian cancer: A 10 steps standardised technique. Surgical and survival outcomes of primary vs. interval surgery. Gynecol Oncol. 2017;144(3):564-70.